Brain's Control Room: Sleep-Wake Cycle Explained

Sleep is one of the most mysterious yet ubiquitous animal behaviours. While it was previously believed that our brain uses several regions to alternate between sleep and wakefulness, new research has found that a single brain area is responsible for controlling both sleep and wakefulness. This area is a tiny cluster of cells within the hypothalamus called the suprachiasmatic nuclei (SCN). The SCN acts as our body's internal clock, helping us know when it's time to be awake and when it's time to sleep based on the light and dark signals they receive.

The role of the thalamic reticular nucleus (TRN) and thalamus

The sleep-wake cycle is influenced by the light-dark cycle, which affects the brain's production and release of hormones such as melatonin and cortisol. Melatonin promotes sleep, while cortisol helps the body prepare for wakefulness.

The thalamic reticular nucleus (TRN) and the thalamus play a crucial role in regulating the sleep-wake cycle. The TRN is a shell-like inhibitory nucleus with anatomical and functional heterogeneity. It is strategically located between the thalamus and the cortex, acting as a "'guardian of the gateway' to the cortex." This unique position allows the TRN to act as a gatekeeper for sensory information entering the thalamus, which then sends it to the cortex for further processing.

The TRN plays a key role in sleep rhythm generation, including sleep spindles, delta waves, and slow oscillations. It induces slow, oscillating brain waves characteristic of deep sleep by relaying signals to the thalamus and then the cortex. With sufficient TRN activity, these waves can spread throughout the brain, potentially aiding in memory consolidation by facilitating information exchange between different brain regions.

The TRN also contributes to regulating selective attention during wakefulness and controlling thalamic and cortical oscillations during sleep. Its intrinsic bursting and tonic spiking patterns are associated with different brain states and functions. For example, TRN tonic spikes are prevalent during wakefulness and attentional states, enabling information transfer from the thalamus and fine-grained inhibitory control over thalamic targets.

Research has shown that stimulating the TRN can induce deep, non-REM-like sleep states, providing insights into the brain's control over arousal and potentially leading to the development of improved sleep aids and anesthetics. The TRN's role in sleep and wakefulness is complex and influenced by various factors, including cellular and synaptic heterogeneities that remain to be fully understood.

Neurotransmitters and their impact

The sleep-wake cycle is regulated by multiple neurotransmitter systems. Neurotransmitters are chemicals that send messages to different nerve cells in the brain. Nerve cells in the brainstem release neurotransmitters, including norepinephrine, histamine, and serotonin. These neurotransmitters act on different parts of the brain to promote alertness and cognitive function during wakefulness.

During the transition from wakefulness to sleep, there are significant changes in motor control, cognition, brain activity, and consciousness. The sleep-wake cycle can be broadly categorized into two distinct sleep states: non-rapid eye movement (NREM) sleep and rapid eye movement (REM) sleep. NREM sleep is further divided into four stages, ranging from light to deep sleep, while REM sleep is characterized by an active cortex, muscle paralysis, and dreaming.

GABA and galanin are inhibitory neurotransmitters that promote NREM sleep by inhibiting wake-promoting systems. The neurons of the ventrolateral preoptic area (VLPO) use GABA and galanin to send inhibitory signals to regions of the brain that promote wakefulness, such as the basal forebrain. The basal forebrain contains GABA-producing neurons, which create arousal by reducing the activity of inhibitory neurons in the cortex, resulting in increased cortical activity. Additionally, the TRN, which surrounds the thalamus, is rich in synapses that release the inhibitory neurotransmitter GABA. Stimulating the TRN can induce deep, non-REM-like sleep states.

On the other hand, acetylcholine (ACh) and monoamine neurotransmitters promote wakefulness and arousal. Monoamine neurotransmitters, including serotonin (5-HT), dopamine (DA), norepinephrine (NE), and histamine, are produced in various regions of the brain and released in the cortex and other areas. They increase neuronal activity and are active during wakefulness but inactive during sleep, especially REM sleep. Acetylcholine, on the other hand, is at its strongest during both REM sleep and wakefulness, and it helps the brain retain and consolidate information.

Abnormalities in neurotransmitter systems can lead to sleep disorders such as insomnia and narcolepsy. Current treatments for these disorders, such as benzodiazepines and nonbenzodiazepines, often have side effects due to the widespread nature of the targeted neurotransmitter systems. The development of more specific treatments for sleep disorders requires a deeper understanding of the underlying neurobiology of the sleep-wake cycle.

The circadian rhythm and the suprachiasmatic nucleus (SCN)

Circadian rhythms are powerful regulators of physiology and behaviour in mammals. The circadian rhythm is directed by the suprachiasmatic nucleus (SCN), a small region of the brain in the hypothalamus, situated directly above the optic chiasm. The SCN is our principal circadian clock, orchestrating the daily cycles of behaviour and physiology that govern our lives.

The SCN is composed of approximately 10,000 neurons on each side of the third ventricle. The SCN's autonomous timing mechanism is both precise and robust, with the ability to persist indefinitely when isolated in organotypic culture. The SCN's role as the central circadian pacemaker was established in early studies, and subsequent research has delved into the underlying molecular, cellular, and circuit mechanisms.

The SCN functions as a circadian biological clock in vertebrates, including teleosts, reptiles, birds, and mammals. In mammals, the SCN drives the rhythms through a transcription-translation negative feedback loop (TTFL) composed of interacting positive and negative transcriptional feedback loops. The genes Clock and Bmal1 (mop3) encode the BHLH-PAS transcription factors CLOCK and BMAL1, which are positive activators that form CLOCK-BMAL1 heterodimers. These heterodimers bind to E-boxes upstream of multiple genes, including per and cry, enhancing their transcription and translation.

The SCN is sensitive to signals of light and dark, receiving input from the optic nerve in the eyes, which detects morning light. This light-dark cycle influences the production and release of hormones like melatonin and cortisol, which play a role in regulating sleep and wakefulness. The SCN also interacts with various brain regions and contains neurotransmitters such as vasopressin and vasoactive intestinal peptide. Disruptions to the SCN have been linked to mood and sleep disorders, highlighting its importance in maintaining circadian timing.

The impact of light and dark

The human sleep-wake cycle is influenced by the light-dark cycle, which affects the production of melatonin, the hormone that makes us feel sleepy. When it is dark, the brain's pineal gland initiates the production of melatonin, and exposure to light slows or stops this process. As the sun rises, the body releases cortisol, which helps us wake up.

The optic nerve in the eye senses the morning light, and the body's internal clock, or circadian rhythm, is controlled by the suprachiasmatic nucleus (SCN) in the brain, which is sensitive to light and dark signals. The SCN is located in the hypothalamus, a small structure deep inside the brain that contains groups of nerve cells that act as control centres for sleep and wakefulness. The SCN receives information about light exposure from the eyes and controls our behavioural rhythm.

When exposed to only natural light, a person's circadian rhythm is closely synchronised with sunrise and sunset, and they stay awake during the day and sleep at night. However, in modern life, artificial light from sources such as streetlights, office lighting, and cell phones can affect the brain's circadian pacemaker. Excessive or poorly timed exposure to artificial light can cause a person's circadian rhythm to become misaligned with the day-night schedule, leading to disrupted sleep and potential health issues such as worsened metabolism, weight gain, and cardiovascular problems.

Light exposure at night can also hinder transitions between sleep cycles, reducing sleep quality. Too much light can cause repeated awakenings and interrupt the sleep cycle, resulting in less time spent in deeper, more restorative sleep stages. Circadian rhythm sleep-wake disorders occur when a person's internal clock is not functioning properly or is misaligned with their environment, and many of these disorders are tied to patterns of light exposure, such as jet lag.

Sleep disorders and their causes

Sleep is vital to a person's health, but many people do not get enough of it. Sleep disorders can be caused by several factors, including age, lifestyle, health, and whether one has been getting enough sleep recently. Older adults, for instance, usually sleep less and wake up earlier. This is because the neurons that promote sleep are lost as part of the ageing process. Conditions such as Alzheimer's disease can also speed up the loss of neurons, making it harder for older adults to stay asleep.

The amount of sleep a person needs also depends on their age. Most adults need about 7-8 hours of sleep each night. However, this can vary depending on other factors such as health and lifestyle. For example, people with heart disease, lung disease, nerve disorders, or pain may require more or less sleep. Those with mental illnesses such as depression and anxiety may also experience sleep disturbances.

One of the most common sleep disorders is insomnia, which affects nearly a third of the adult population. People with insomnia have trouble falling asleep, staying asleep, or both, resulting in a lack of sleep or poor sleep quality. Narcolepsy is another sleep disorder that causes extreme daytime sleepiness and, in some cases, muscle weakness. Other sleep disorders include restless legs syndrome, which may be triggered by abnormalities in the neurotransmitter dopamine, and sleep apnea, which can be treated with a CPAP machine.

The body's internal clock, or circadian rhythm, is controlled by an area of the brain called the SCN (suprachiasmatic nucleus), which is located in the hypothalamus. The SCN is sensitive to light and dark signals, and it triggers the release of hormones such as cortisol and melatonin to help regulate sleep and wakefulness. When there is darkness, the SCN sends a message to the pineal gland to release melatonin, which makes us feel sleepy. When it is light, the body releases cortisol, which helps prepare the body to wake up.

Abnormalities in the circadian rhythm can lead to sleep disturbances. Jet lag, for example, occurs when the central circadian clock is not properly aligned with the sleep time, such as when travelling to a new time zone. This usually resolves within a few days. However, other factors such as exposure to bright artificial light in the evening can also disrupt the release of melatonin and make it harder to fall asleep.

Frequently asked questions